These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 37592775)
21. The Opportunities and Challenges of Silica Nanomaterial for Atherosclerosis. Sha X; Dai Y; Song X; Liu S; Zhang S; Li J Int J Nanomedicine; 2021; 16():701-714. PubMed ID: 33536755 [TBL] [Abstract][Full Text] [Related]
22. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy. Murugan B; Krishnan UM Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004 [TBL] [Abstract][Full Text] [Related]
23. Comparative Study on Photodynamic Activation of Ortho-Toluidine Blue and Methylene Blue Loaded Mesoporous Silica Nanoparticles Against Resistant Microorganisms. Amin A; Kaduskar DV Recent Pat Drug Deliv Formul; 2018; 12(3):154-161. PubMed ID: 29952275 [TBL] [Abstract][Full Text] [Related]
24. Intravitreal safety profiles of sol-gel mesoporous silica microparticles and the degradation product (Si(OH) Sun Y; Huffman K; Freeman WR; Sailor MJ; Cheng L Drug Deliv; 2020 Dec; 27(1):703-711. PubMed ID: 32393079 [TBL] [Abstract][Full Text] [Related]
25. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis. Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879 [TBL] [Abstract][Full Text] [Related]
28. A Comparative Study of Mesoporous Silica and Mesoporous Bioactive Glass Nanoparticles as Non-Viral MicroRNA Vectors for Osteogenesis. Hosseinpour S; Gomez-Cerezo MN; Cao Y; Lei C; Dai H; Walsh LJ; Ivanovski S; Xu C Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365121 [TBL] [Abstract][Full Text] [Related]
29. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Li Z; Zhang Y; Feng N Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075 [TBL] [Abstract][Full Text] [Related]
30. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles. Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882 [TBL] [Abstract][Full Text] [Related]
31. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis. Gupta A; Kushwaha SS; Mishra A Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094 [TBL] [Abstract][Full Text] [Related]
32. Efficient delivery of abciximab using mesoporous silica nanoparticles: In-vitro assessment for targeted and improved antithrombotic activity. Priya V; Vikas ; Mehata AK; Jain D; Singh SK; Muthu MS Colloids Surf B Biointerfaces; 2022 Oct; 218():112697. PubMed ID: 35917688 [TBL] [Abstract][Full Text] [Related]
33. Shape matters when engineering mesoporous silica-based nanomedicines. Hao N; Li L; Tang F Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852 [TBL] [Abstract][Full Text] [Related]
34. pH-responsive and targeted delivery of chrysin via folic acid-functionalized mesoporous silica nanocarrier for breast cancer therapy. Ghosh N; Kundu M; Ghosh S; Das AK; De S; Das J; Sil PC Int J Pharm; 2023 Jan; 631():122555. PubMed ID: 36586636 [TBL] [Abstract][Full Text] [Related]
35. Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy. Koohi Moftakhari Esfahani M; Alavi SE; Cabot PJ; Islam N; Izake EL Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015204 [TBL] [Abstract][Full Text] [Related]
36. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC). Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385 [TBL] [Abstract][Full Text] [Related]
37. Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapy. Li Y; Deng G; Hu X; Li C; Wang X; Zhu Q; Zheng K; Xiong W; Wu H Nanomedicine (Lond); 2022 Aug; 17(18):1253-1279. PubMed ID: 36250937 [TBL] [Abstract][Full Text] [Related]